AFFECTIVE AND COGNITIVE CONSEQUENCES OF ECT
AFFECTIVE AND COGNITIVE CONSEQUENCES OF ECT
批准号:
6647038
负责人:
HAROLD A. SACKEIM
金额:
$39.4万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 2004-11-30
关键词:
antidepressants antipsychotic agents bipolar depression manic phase brain circulation clinical research clinical trials cognition electroconvulsive therapy electroencephalography gender difference human subject human therapy evaluation major depression mental disorder chemotherapy neuropsychological tests remission /regression schizophrenia seasonal affective disorder
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): This R01 is a competitive
renewal of a MERIT Award. When this project started (1981), the universal view
was that the efficacy of ECT was dependent on the generalized seizure, while
its cognitive effects were largely determined by electrical dosage.
Nonetheless, standard practice involved treating all patients with the same
electrical dose, typically at device maximum. Across three studies, we
demonstrated marked individual differences in seizure threshold (ST). Many
patients were treated orders of magnitude above ST, accounting for much of the
adverse cognitive effects of ECT. We also demonstrated that the efficacy of
right unilateral (RUL)ECT is highly dependent on the degree to which dosage
exceeds ST. These findings have been widely replicated. In our most recent
study (started and completed during the MERIT Award period), high dosage RUL
ECT equaled the efficacy of a robust form of bilateral (BL) ECT, and had
clinically significant advantages in acute, short-term, and long-term cognitive
side effects. These findings have already had impact on practice, and should
help resolve the > 40 year controversy regarding the relative merits of RUL and
BL ECT.
The proposed study (Study 4) began during the MERIT Award period, and this
application requests support for its completion. In addition to replicating the
key findings regarding the relative merits of high dosage RUL compared to BL
ECT, this study takes a new direction. The traditional ECT stimulus
configuration is nonphysiologic. The standard pulse width (PW) used in ECT (1-2
ms) greatly exceeds the chronaxie for the optimal stimulation necessary for
neuronal depoladzation and seizure production (eg, 0.04-0.2 ms). Excessive PW
results in stimulation during refractory periods long following neuronal
discharge. By reducing the PW of the ECT stimulus, we should maintain efficacy,
but substantially reduce cognitive side effects. Our preliminary data suggest
that the magnitude of this effect equals or exceeds the difference in cognitive
effects between RUL and BL ECT, and, in fact, the extraordinary difference
between sine wave and brief pulse stimulation. This new study uses a
randomized, double-masked, parallel group, fully factorial [RUL vs. BL ECT and
ultrabrief PW (0 ms) vs. traditional PW (1.5 ms)] design, with both RUL
conditions treated at 6 times initial ST and both BL conditions treated at 2.5
times initial ST. We hypothesize that high dose RUL ECT has significant
advantages over moderate dose BL ECT [with both at traditional PW]. Most
critically, use of an ultrabrief PW is equally effective as a long PW, but
markedly reduces the short- and long-term cognitive burden of ECT, and is also
superior in effects on functional status, subjective cognitive outcome, and
neurophysiological alterations. Such findings should have fundamental impact on
our understanding of mechanisms and on the practice of ECT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core--Clinical evaluation
-
批准号:6643687
-
项目类别:
-
资助金额:$17.72万
-
财政年份:2002
-
负责人:HAROLD A. SACKEIM
-
依托单位:
Core--Clinical evaluation
-
批准号:6480789
-
项目类别:
-
资助金额:$17.72万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
-
批准号:6629282
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
-
批准号:6260485
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
-
批准号:6841642
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
-
批准号:6691744
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
OPTIMIZATION OF ELECTROCONVULSIVE THERAPY
-
批准号:6499375
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2001
-
负责人:HAROLD A. SACKEIM
-
依托单位:
Core--Clinical evaluation
-
批准号:6339877
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2000
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
-
批准号:6343721
-
项目类别:
-
资助金额:$21.32万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:2890927
-
项目类别:
-
资助金额:$8.4万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
-
批准号:2034705
-
项目类别:
-
资助金额:$38.91万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
-
批准号:2858040
-
项目类别:
-
资助金额:$45.41万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
-
批准号:6139396
-
项目类别:
-
资助金额:$45.83万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:2675622
-
项目类别:
-
资助金额:$15.75万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:2035644
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
-
批准号:2635526
-
项目类别:
-
资助金额:$39.31万
-
财政年份:1997
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:2247800
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1992
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:2247799
-
项目类别:
-
资助金额:$18.3万
-
财政年份:1992
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:3387516
-
项目类别:
-
资助金额:$18.24万
-
财政年份:1992
-
负责人:HAROLD A. SACKEIM
-
依托单位:
CONTINUATION PHARMACOTHERAPY FOLLOWING ECT
-
批准号:3387517
-
项目类别:
-
资助金额:$15.9万
-
财政年份:1992
-
负责人:HAROLD A. SACKEIM
-
依托单位:
海外基金